|
JAMA Oncology |
Human Leukocyte Antigen Class I Antigen-Processing Machinery Upregulation by Anticancer Therapies in the Era of Checkpoint Inhibitors |
1 |
Yes |
3/17/2025 |
|
JAMA Oncology |
Human Leukocyte Antigen Class I Antigen-Processing Machinery Upregulation by Anticancer Therapies in the Era of Checkpoint Inhibitors |
1 |
Yes |
3/17/2025 |
|
JAMA Oncology |
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients |
1 |
Yes |
3/18/2025 |
|
JAMA Oncology |
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients |
1 |
Yes |
3/18/2025 |
|
JAMA Oncology |
Identification of Deaths Caused by Cancer and COVID-19 in the US During March to December 2020 |
1 |
Yes |
10/26/2025 |
|
JAMA Oncology |
Identification of Deaths Caused by Cancer and COVID-19 in the US During March to December 2020 |
1 |
Yes |
10/26/2025 |
|
JAMA Oncology |
Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma - A Review |
1 |
Yes |
12/14/2026 |
|
JAMA Oncology |
Immunotherapy in the Treatment of Localized Genitourinary Cancers |
1 |
Yes |
8/10/2026 |
|
JAMA Oncology |
Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer |
1 |
Yes |
9/23/2025 |
|
JAMA Oncology |
Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer |
1 |
Yes |
9/23/2025 |
|
JAMA Oncology |
Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer - The FAST Multidisciplinary Group Consensus Statement |
1 |
Yes |
7/11/2027 |
|
JAMA Oncology |
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates |
1 |
Yes |
12/16/2024 |
|
JAMA Oncology |
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates - A Review |
1 |
Yes |
12/16/2024 |
|
JAMA Oncology |
Left Axilla Adenocarcinoma of Unknown Origin |
1 |
Yes |
3/16/2026 |
|
JAMA Oncology |
Left Shoulder Fungating Mass in a 46-Year-Old Man |
1 |
Yes |
6/15/2026 |
|
JAMA Oncology |
Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors |
1 |
Yes |
4/22/2025 |
|
JAMA Oncology |
Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors |
1 |
Yes |
4/22/2025 |
|
JAMA Oncology |
Lymphoma With a Skin Rash |
1 |
Yes |
6/6/2027 |
|
JAMA Oncology |
Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors |
1 |
Yes |
1/20/2025 |
|
JAMA Oncology |
Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors - A Systematic Review |
1 |
Yes |
1/20/2025 |
